+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Roche Diagnostics Ltd. - logo

Founded in Basel, Switzerland in 1896, Roche produces innovative medicines and diagnostic tests for the early detection, prevention, diagnosis and treatment of diseases including oncology, rheumatology, virology, transplantation, diabetes and immunology. They are the world’s leading biotech company and have been at the forefront of cancer research and treatment for more than 50 years, in addition to being the leading provider of in vitro diagnostics.

2024 Middle East Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - An 11-Country Analysis - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 Middle East Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - An 11-Country Analysis - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts

  • Report
  • May 2024
  • Middle East
From
2024 Latin America Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - A 22-Country Analysis - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 Latin America Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - A 22-Country Analysis - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts

  • Report
  • May 2024
  • Latin America
From
2024 Asia-Pacific Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - An 18-Country Analysis - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 Asia-Pacific Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - An 18-Country Analysis - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts

  • Report
  • May 2024
  • Asia Pacific
From
2024 World Tumor Marker Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - A 92-Country Analysis - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 World Tumor Marker Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - A 92-Country Analysis - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts

  • Report
  • May 2024
  • Global
From
Transarterial Chemoembolization - Global Strategic Business Report - Product Thumbnail Image

Transarterial Chemoembolization - Global Strategic Business Report

  • Report
  • August 2025
  • 375 Pages
  • Global
From
GLP-1 Analogues - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Analogues - Global Strategic Business Report

  • Report
  • August 2025
  • 474 Pages
  • Global
From
Retinal Biologics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Retinal Biologics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • October 2022
  • 110 Pages
  • Global
From
Cold Agglutinin Disease Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cold Agglutinin Disease Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
ACTEMRA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ACTEMRA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Tourette Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Tourette Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • November 2022
  • 691 Pages
  • Global
From
Anti-Retroviral Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Retroviral Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 280 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups

  • Report
  • September 2022
  • 559 Pages
  • Spain
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Italy Edition: The Views of 103 Italian Patient Groups

  • Report
  • September 2022
  • 59 Pages
  • Italy
Pancreatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Pancreatic Cancer Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 151 Pages
  • Global
From
Pancreatic Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Pancreatic Cancer Treatment - Global Strategic Business Report

  • Report
  • August 2025
  • 381 Pages
  • Global
From
Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024

  • Clinical Trials
  • April 2024
  • 481 Pages
  • Global
From
Global Biosimilars Partnering Terms and Agreements 2010 to 2023 - Product Thumbnail Image

Global Biosimilars Partnering Terms and Agreements 2010 to 2023

  • Report
  • June 2023
  • 150 Pages
  • Global
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Loading Indicator